Filing Flows › Xtant Medical Holdings (XTNT) › Capital expenditures
Xtant Medical Holdings (XTNT) capital expenditures by quarter
Xtant Medical Holdings' capital expenditures were $395K in Q4 2025 (fourth quarter 2025), -8% from Q3 2025. Over the last 5 quarters it ranged from $366K (Q2 2025) to $1.2M (Q1 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q4 2025 | $395K | -8% | -41% |
| Q3 2025 | $430K | +17% | — |
| Q2 2025 | $366K | -69% | — |
| Q1 2025 | $1.2M | +77% | — |
| Q4 2024 | $672K | — | — |
Q4 2025 at a glance
Xtant Medical Holdings, Q4 2025: revenue $32.4M (+3% year over year), operating margin -2.9%, net earnings $57K, operating cash flow $5.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Xtant Medical Holdings' capital expenditures?
Xtant Medical Holdings' capital expenditures were $395K in Q4 2025 (fourth quarter 2025), -8% from Q3 2025.
How has Xtant Medical Holdings' capital expenditures changed?
Over the last 5 quarters it ranged from $366K (Q2 2025) to $1.2M (Q1 2025).
Q4 2025 results → · How Xtant Medical Holdings makes money →